Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
JoAnn Clair
Observed name:
J Clair
Institution:
Kiniksa Pharmaceuticals (United States)
Observed institution:
Kiniksa Pharmaceuticals (United States)
ORCID:
0000-0003-0281-1651
Observed ORCID:
0000-0003-0281-1651
OpenAlex ID:
A5028734787
Sustained Pericarditis Recurrence Risk Reduction With Long‐Term Rilonacept
2024
·
Massimo Imazio
, Allan L. Klein
, et al.
·
Journal of the American Heart Association
·
48
PDF
Longitudinal cardiac magnetic resonance imaging following clinical response to rilonacept and prior to recurrence upon treatment suspension: a RHAPSODY subgroup analysis
2024
·
Paul C Cremer
, Antonio Brucato
, et al.
·
European Heart Journal - Cardiovascular Imaging
·
6
Absence of Pericarditis Recurrence in Rilonacept-Treated Patients With COVID-19 and SARS-CoV-2 Vaccination: Results From the RHAPSODY Long-term Extension
2024
·
Antonio Brucato
, Lucia Trotta
, et al.
·
CJC Open
·
6
PDF
IL-1 Pathway Inhibition in Recurrent Pericarditis Management
2025
·
Paul C. Cremer
, Sushil A. Luis
, et al.
·
JACC Advances
·
3
Rilonacept Utilization in a Steroid-sparing Paradigm for Recurrent Pericarditis: Real World Evidence Demonstrating Increased Adoption
2024
·
Sushil Allen Luis
, Paul Cremer
, et al.
·
Journal of the American College of Cardiology
·
2
Multiyear Recurrent Pericarditis Disease Duration: Clinical Outcomes After Cessation of Long‐Term Interleukin‐1 Pathway Inhibition Provide Insights for Chronic Management
2026
·
Lucia Trotta
, Massimo Imazio
, et al.
·
Journal of the American Heart Association
·
1
Comment on “Risk of Pericarditis Recurrence Associated With Rilonacept and NSAID/Colchicine Therapy After Initial Pericarditis Presentation: A Retrospective Real-World Comparative Risk Analysis With TriNetX”
2026
·
Vidhya Parameswaran
, Sheldon Wang
, et al.
·
American Journal of Therapeutics
Rilonacept reduces pericarditis recurrence risk: clinical outcomes from the RESONANCE patient registry
2025
·
P C Cremer
, M Garshick
, et al.
·
European Heart Journal
Rilonacept as monotherapy for long-term recurrent pericarditis management: sustained disease control over three years
2025
·
D Lotan
, M Imazio
, et al.
·
European Heart Journal
Cardiac magnetic resonance imaging paralleled recurrent pericarditis clinical response to rilonacept treatment over 18 months: a RHAPSODY subgroup analysis
2024
·
AAMER KHAN
, Paul C
, et al.
Rilonacept Utilization in a Steroid-sparing Paradigm for Recurrent Pericarditis: Real-world Evidence Demonstrating Increased Adoption
2024
·
AAMER KHAN
, Allen Luis
, et al.
Abstract 11536: Cardiac Magnetic Resonance Imaging Paralleled Recurrent Pericarditis Clinical Response to Rilonacept Treatment Over 18 Months: A RHAPSODY Subgroup Analysis
2023
·
Paul C Cremer
, Antonio Brucato
, et al.
·
Circulation
Baseline Demographics and Disease Characteristics of Patients Enrolled in the Registry of the Natural History of Recurrent Pericarditis in Pediatric and Adult Patients (resonance)
2023
·
JoAnn Clair
, Paul Cremer
, et al.
·
Journal of the American College of Cardiology
Show more works
View as search
Works count:
13
Citation count:
66
H-index:
3
I10-index:
1
Year
Topic
Type